| Primary |
| Benign Prostatic Hyperplasia |
58.5% |
| Product Used For Unknown Indication |
15.4% |
| Prostatomegaly |
9.6% |
| Prostatic Disorder |
3.6% |
| Nocturia |
2.5% |
| Pollakiuria |
2.5% |
| Dysuria |
1.4% |
| Micturition Disorder |
0.8% |
| Prostate Cancer Metastatic |
0.8% |
| Prostatic Specific Antigen Increased |
0.8% |
| Urinary Incontinence |
0.8% |
| Arthritis |
0.5% |
| Bladder Disorder |
0.5% |
| Hypertension |
0.5% |
| Bladder Cancer |
0.3% |
| Blood Cholesterol |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Blood Pressure |
0.3% |
| Exposure Via Body Fluid |
0.3% |
| Haemorrhage Urinary Tract |
0.3% |
|
| Drug Ineffective |
13.1% |
| Rash |
10.7% |
| Dizziness |
9.5% |
| Erectile Dysfunction |
8.9% |
| Gynaecomastia |
4.8% |
| Pruritus |
4.8% |
| Urticaria |
4.8% |
| Dyspnoea |
4.2% |
| Product Quality Issue |
4.2% |
| Breast Tenderness |
3.6% |
| Diarrhoea |
3.6% |
| Dyspepsia |
3.6% |
| Headache |
3.6% |
| Oedema Peripheral |
3.6% |
| Back Pain |
3.0% |
| Ejaculation Disorder |
3.0% |
| Pollakiuria |
3.0% |
| Testicular Pain |
3.0% |
| Therapeutic Response Decreased |
3.0% |
| Ejaculation Failure |
2.4% |
|
| Secondary |
| Benign Prostatic Hyperplasia |
48.4% |
| Prostatomegaly |
32.3% |
| Product Used For Unknown Indication |
12.9% |
| Blood Pressure Abnormal |
3.2% |
| Prostatic Specific Antigen Increased |
3.2% |
|
| Drug Ineffective |
11.8% |
| Blood Creatinine Increased |
5.9% |
| Breast Tenderness |
5.9% |
| Dizziness |
5.9% |
| Genital Pain |
5.9% |
| Gynaecomastia |
5.9% |
| Hyperhidrosis |
5.9% |
| Lip Swelling |
5.9% |
| Loss Of Libido |
5.9% |
| Muscle Tightness |
5.9% |
| Myalgia |
5.9% |
| Pain In Jaw |
5.9% |
| Rhinorrhoea |
5.9% |
| Sexual Dysfunction |
5.9% |
| Syncope |
5.9% |
| Urinary Tract Infection |
5.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.5% |
| Drug Use For Unknown Indication |
9.3% |
| Medical Diet |
8.6% |
| Hypertension |
8.1% |
| Rheumatoid Arthritis |
6.5% |
| Gastrooesophageal Reflux Disease |
4.4% |
| Benign Prostatic Hyperplasia |
3.7% |
| Prophylaxis |
3.7% |
| Pain |
3.5% |
| Blood Pressure |
3.2% |
| Atrial Fibrillation |
2.8% |
| Blood Cholesterol Increased |
2.3% |
| Hepatitis C |
2.1% |
| Prostatic Disorder |
2.1% |
| High Density Lipoprotein Decreased |
1.6% |
| Vitamin Supplementation |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Depression |
1.4% |
| Back Pain |
1.2% |
| Crohn's Disease |
1.2% |
|
| Cerebral Haemorrhage |
10.5% |
| Drug Ineffective |
10.5% |
| Platelet Count Decreased |
7.9% |
| Choking Sensation |
5.3% |
| Erythema |
5.3% |
| Fall |
5.3% |
| Flushing |
5.3% |
| Mouth Haemorrhage |
5.3% |
| Nasal Congestion |
5.3% |
| Nausea |
5.3% |
| Pruritus |
5.3% |
| Tooth Infection |
5.3% |
| Urinary Hesitation |
5.3% |
| Anal Haemorrhage |
2.6% |
| Anosmia |
2.6% |
| Back Pain |
2.6% |
| Blood Glucose Increased |
2.6% |
| Blood Pressure Inadequately Controlled |
2.6% |
| Blood Pressure Increased |
2.6% |
| Bronchitis |
2.6% |
|
